Dietary metabolites derived from gut microbiota: Critical modulators of epigenetic changes in mammals

Nutrition Reviews

Volumn 75, Issue 5, 2017, Pages 374-389

  Bhat, Mohd Iqbal ^a   Kapila, Rajeev ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Epigenetic reprogramming; Histone modifications; Microbial metabolites; Microbiome; Probiotics

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CYANOCOBALAMIN; DNA METHYLTRANSFERASE; FOLIC ACID; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; PHOSPHOTRANSFERASE; POLYAMINE; POLYPHENOL; PROBIOTIC AGENT; PYRIDOXINE; RIBOFLAVIN; RNA; SHORT CHAIN FATTY ACID; VITAMIN; FATTY ACID;

ACETYLATION; ARTICLE; BIOTINYLATION; DEACETYLATION; DEMETHYLATION; DNA MODIFICATION; EPIGENETICS; HOST PATHOGEN INTERACTION; INTESTINE FLORA; MAMMAL; METABOLITE; METHYLATION; NONHUMAN; PHOSPHORYLATION; RNA INTERFERENCE; ANIMAL; DIET; GENETIC EPIGENESIS; HUMAN; METABOLISM;

ACETYLATION; ANIMALS; BIOTINYLATION; DIET; EPIGENESIS, GENETIC; EPIGENOMICS; FATTY ACIDS; GASTROINTESTINAL MICROBIOME; HUMANS; METHYLATION; PHOSPHORYLATION; RNA INTERFERENCE;

EID: 85027142463     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nux001     Document Type: Article

References (128)

1. Vinje S, Stroes E, Nieuwdorp M, et al. The gut microbiome as novel cardiometabolic target: the time has come! Eur Heart J. 2014;35:883-887
2. Forsythe P, Kunze WA. Voices from within gut: gut microbes and the CNS. Cell Mol Life Sci. 2013;70:55-69
3. Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol. 2008;24:4-10
4. Reiff C, Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol. 2010;300:25-33
5. Petrof EO. Probiotics and gastrointestinal disease: clinical evidence and basic science. Antiinflamm Antiallergy Agents Med Chem. 2009;8:260-269
6. Mikov MM, Stojancevic MP, Bojic GM. Probiotics as a promising treatment for inflammatory bowel disease. Hosp Pharmacol. 2014;1:52-60
7. Renz H, von Mutius E, Brandtzaeg P, et al. Gene-environment interactions in chronic inflammatory disease. Nat Immunol. 2011;12:273-277
8. Slomko H, Heo HJ, Einstein FH. Minireview: epigenetics of obesity and diabetes in humans. Endocrinology. 2012;153:1025-1030
9. Mukherjee AB, Zhang Z. Allergic asthma: influence of genetic and environmental factors. J Biol Chem. 2011;286:32883-32889
10. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433-440
11. Feinberg AP. Epigenetics at the epicenter of modern medicine. JAMA. 2008;299:1345-1350
12. Tollefsbol TO. Handbook of Epigenetics: the New Molecular and Medical Genetics. London, England: Academic Press; 2010:618
13. Shenderov BA. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis. 2012;23:17195. doi:10.3402/mehd.v23i0.17195
14. Safronova O, Morita I. Transcriptome remodeling in hypoxic inflammation. J Dent Res. 2010;89:430-444
15. Qureshi SA, Bashir MU, Yaqinuddin A. Utility of DNA methylation markers for diagnosing cancer. Int J Surg. 2010;8:194-198
16. Oka T, Sato H, Ouchida M, et al. Cumulative epigenetic abnormalities in host genes with viral and microbial infection during initiation and progression of malignant lymphoma/leukemia. Cancers. 2011;3:568-581
17. Kumar H, Lund R, Laiho A, et al. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio. 2014;5:2113-2114
18. Paul B, Barnes S, Demark-Wahnefried W, et al. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenetics. 2015;7:112. doi:10.1186/s13148-015-0144-7
19. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem. 2001;70: 81-120
20. Marmorstein R. Structure of histone acetyltransferases. J Mol Biol. 2001;311: 433-444
21. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32-42
22. Donohoe DR, Bultman SJ. Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol. 2012;227:3169-3177
23. Rotili D, Mai A. Targeting histone demethylases: a new avenue for the fight against cancer. Genes Cancer. 2011;2:663-679
24. Hermann A, Schmitt S, Jeltsch A. The human Dnmt2 has residual DNA-(Cytosine-C5) methyltransferase activity. J Biol Chem. 2003;278:31717-31721
25. Huangand Y, Rao A. Connections between TET proteins and aberrant DNA modification in cancer Trends Genet. 2014;30:464-474
26. Schaap FG, French PJ, Bovee JV. Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors. Adv Anat Pathol. 2013;20:32-38
27. Kobza K, Sarath G, Zempleni J. Prokaryotic BirA ligase biotinylates K4, K9, K18 and K23 in histone H3. BMB Reports. 2008;41:1-6
28. Haller D, Holt L, Kim SC, et al. Transforming growth factor-b1 inhibits nonpathogenic gram negative bacteria-induced NF-jB recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J Biol Chem. 2003;278:23851-23860
29. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA. 2007;104:15805-15810
30. Varambally S, Cao Q, Mani RS. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science. 2008;322: 1695-1699
31. Noonan EJ, Place RF, Pookot D. MiR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene. 2009;28:1714-1724
32. Huang V, Place RF, Portnoy V, et al. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 2012;40:1695-1707
33. Sauve AA, Wolberger C, Schramm VL, et al. The biochemistry of sirtuins. Annu Rev Biochem. 2006;75:435-465
34. Chena X, Barozzib I, Termaninib A, et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci USA. 2012;109:2865-2874
35. Aoyama M, Kotani J, Usami M. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition. 2010;26:653-661
36. Kim GW, Gocevski G, Wu CJ, et al. Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery. Int J Cell Biol. 2010;632739. doi:10.1155/2010/632739
37. Waby JS, Chirakkal H, Yu C, et al. Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line. Mol Cancer. 2010;9:275. doi:10.1186/1476-4598-9-275
38. Takahashi K, Nakano YSK, Tsuda M, et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem. 2011;286: 35755-35762
39. Ganal SC, Sanos SL, Kallfass C, et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity. 2012;37:171-186
40. Chew YC, West T, Kratzer SJ, et al. Biotinylation of histones represses transposable elements in human and mouse cells and cell lines and in Drosophila melanogaster. J Nutr. 2008;138:2316-2322
41. Singh MP, Wijeratne SSK, Zempleni J. Biotinylation of lysine 16 in histone H4 contributes toward nucleosome condensation. Arch Biochem Biophys. 2013;529: 105-111
42. Xue J, Zempleni J. Epigenetic synergies between biotin and folate in the regulation of pro-inflammatory cytokines and repeats. Scand J Immunol. 2013;78: 419-425
43. Xue J, Zhou J, Zempleni J. Holocarboxylase synthetase catalyzes biotinylation of heat shock protein 72, thereby inducing RANTES expression in HEK-293 cells. Am J Physiol Cell Physiol. 2013;305:C1240-C1245
44. Bao B, Rodriguez-Melendez R, Wijeratne SS, et al. Biotin regulates the expression of holocarboxylase synthetase in the miR-539 pathway in HEK-293 cells. J Nutr. 2010;140:1546-1551
45. Reinhardt C, Bergentall M, Greiner TU. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature. 2012;483:627-631
46. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718-15723
47. Place RF, Li LC, Pookot D, et al. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A. 2008;105: 1608-1613
48. Zardo G, Ciolfi A, Vian L, et al. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood. 2012;119:4034-4046
49. Singh N, Shirdel EA, Waldron L, et al. The murine caecal microRNA signature depends on the presence of the endogenous microbiota. Int J Biol Sci. 2012;8:171-186
50. Dalmasso G, Nguyen HTT, Yan Y, et al. Microbiota modulate host gene expression via microRNAs. PLoS One. 2011;6:e19293. doi:10.1371/journal.pone.0019293
51. Archambaud G, Sismeiro O, Toedling DG, et al. The intestinal microbiota interferes with the microRNA response upon oral Listeria infection. MBio. 2013;4:e00707-e00713
52. Xue X, Feng T, Yao S, et al. Microbiota down regulates dendritic cell expression of miR-10a which targets IL-12/IL-23p40. J Immunol. 2011;187:5879-5886
53. Veltman KHS, Cichon C, Sonnenborn U, et al. Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells. Int J Biochem Cell Biol. 2012;44:341-349
54. Greer JB, O'Keefe SJ. Microbial induction of immunity, inflammation, and cancer. Front Physiol. 2011;1:168. doi:10.3389/fphys.2010.00168
55. Alenghat T, Artis D. Epigenomic regulation of host-microbiota interactions. Trends Immunol. 2014;35:518-525
56. Shenderov BA. Probiotic (symbiotic) bacterial languages. Anaerobe. 2011;17:490-495
57. Stewart TM, Woster PM, Casero JRA. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines. Amino Acids. 2014;46:585-594
58. Soliman ML, Combs CK, Rosenberger TA. Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes. J Neuroimmune Pharmacol. 2013;8:287-300
59. Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by bhydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339:211-214
60. Nandakumar V, Vaid M, Katiyar SK. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 2011;32:537-544
61. Kim HJ, Kim SH, Yun JM. Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms. Evid-Based Compl Altern Med. 2012;2012:639469
62. Vinolo MAR, Rodrigues HG, Nachbar RT, et al. Regulation of inflammation by short chain fatty acids. Nutrition. 2011;3:858-876
63. Kim MH, Kang SG, Park JH, et al. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013;145:396-406
64. Chang PV, Hao L, Offermanns S, et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111:2247-2252
65. Canani RB, Costanzo MD, Leone L, et al. Potential beneficial effects of butyrate in intestinal and extra-intestinal diseases. World J Gastroenterol. 2011;17:1519-1528
66. Soliman ML, Rosenberger TA. Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression. Mol Cell Biochem. 2011;352:173-180
67. Soliman ML, Puig KL, Combs CK, et al. Acetate reduces microglia inflammatory signaling in vitro. J Neurochem. 2012;123:555-567
68. Brissette CA, Houdek HM, Floden AM, et al. Acetate supplementation reduces microglia activation and brain interleukin-1b levels in a rat model of Lyme neuroborreliosis. J Neuroinflammation. 2012;9:249. doi:10.1186/1742-2094-9-249
69. Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol. 2007;17:363-369
70. Scharlau D, Borowicki A, Habermann N. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res. 2009;682:39-53
71. Bordonaro M, Lazarova DL, Sartorelli AC. Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle. 2008;7:1178-1183
72. Hamer HM, Jonkers D, Venema K, et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104-119
73. Hallert C, Bjorck I, Nyman M, et al. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis. 2003;9:116-121
74. Vinolo MAR, Rodrigues HG, Hatanaka E, et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22:849-855
75. Furusawa Y, Obata Y, Fukude S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504: 446-450
76. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451-455
77. Chang PV, Hao L, Offermanns S, et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111:2247-2252
78. Gao Z, Yin J, Zhang J, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58:1509-1517
79. Malia P, Choua BK, Yena J, et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells. 2010;28:713-720
80. Kato K, Kuhara A, Yoneda T, et al. Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response. Mol Cancer Ther. 2011;10:1430-1439
81. Waldecker M, Kautenburger T, Daumann H, et al. Inhibition of histonedeacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem. 2008;19:587-593
82. Kibe R, Kurihara S, Sakai Y, et al. Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice. Sci Rep. 2014;4:4548. doi:10.1038/srep04548
83. Matsumoto M, Kurihara S, Kib R, et al. Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One. 2011;6:23652. doi:10.1371/journal.pone.0023652
84. Alenghat T, Osborne LC, Saenz SA, et al. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature. 2013;504: 153-157
85. Turgeon N, Gagne JM, Blais M, et al. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2014;306:594-605
86. Simon GM, Cheng J, Gordon JI. Quantitative assessment of the impact of the gut microbiota on lysine epsilon-acetylation of host proteins using gnotobiotic mice. Proc Natl Acad Sci USA. 2012;109:11133-11138
87. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014;13:69-86
88. Monsey MS, Ota KT, Akingbade IF, et al. Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala. PLoS One. 2011;6:19958. doi:10.1371/journal.pone.0019958
89. Noack J, Dongowski G, Hartmann L, et al. The human gut bacteria Bacteroides thetaiotaomicron and Fusobacterium varium produce putrescine and spermidine in cecum of pectin-fed gnotobiotic rats. J Nutr. 2000;130:1225-1231
90. Bourassa MW, Alim I, Bultman SJ, et al. Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health? Neurosci Lett. 2016;20:56-63
91. Gardian G, Brownw SE, Choi DK, et al. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem. 2005;280:556-563
92. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202-209
93. Leonard SM, Wei W, Collins SI, et al. Oncogenic human papilloma virus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women. Carcinogenesis. 2012;33: 1286-1293
94. Laurson J, Khan S, Chung R, et al. Epigenetic repression of E-cadherin by human papilloma virus 16 E7 protein. Carcinogenesis. 2010;31:918-926
95. Tolg C, Sabha N, Cortese R, et al. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab Invest. 2011;91:825-836
96. Ding SZ, Fischer W, Kaparakis-Liaskos M, et al. Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS One. 2010;5:9875. doi:10.1371/journal.pone.0009875
97. Sepulveda AR, Yao Y, Yan W, et al. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology. 2010;1381:836-844
98. Doherty R, O'Farrelly C, Meade K. Epigenetic regulation of the innate immune response to LPS in bovine peripheral blood mononuclear cells (PBMC). Vet Immunol Immunopathol. 2013;154:102-110
99. Ebenezer D, Zhao Y, Ackerman S, et al. Epigenetic regulation of LPS-induced lung injury by sphingosine-1-phosphate lyase (1001.10). FASEB J. 2014;28:1001-1010
100. LeBlanc JG, Milani C, de Giori GS, et al. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2013;24:160-168
101. Huang J, Plass C, Gerhauser C. Cancer chemoprevention by targeting the epigenome. Curr Drug Targets. 2011;12:1925-1956
102. Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J Nutr Biochem. 2012;23:853-859
103. Rampersaud GC, Kauwell GP, Hutson AD, et al. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr. 2000;72:998-1003
104. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, et al. Periconceptional maternal folic acid use of 400 lg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One. 2009;16;4:e7845. doi:10.1371/journal.pone.0007845
105. Junaid MA, Kuizon S, Cardona J, et al. Folic acid supplementation dysregulates gene expression in lymphoblastoid cells-implications in nutrition. Biochem Biophys Res Commun. 2011;412:688-692
106. Ichi S, Costa FF, Bischof JM, et al. Folic acid remodels chromatin on Hes1 and Neurog2 promoters during caudal neural tube development. J Biol Chem. 2010;285:36922-36932
107. Barua S, Kuizon S, Junaid MA. Folic acid supplementation in pregnancy and implications in health and disease. J Biomed Sci. 2014;21:77. doi:10.1186/s12929-014-0077-z
108. Kok DE, Dhonukshe-Rutten RA, Lute C. The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects. Clin Epigenetics. 2015;14:121. doi:10.1186/s13148-015-0154-5
109. Liu H, Tian T, Qin S, et al. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression. J Nutr Biochem. 2015;26:1502-1508
110. Li W, Liu H, Yu M, et al. Folic acid administration inhibits amyloid b-peptide accumulation in APP/PS1 transgenic mice. J Nutr Biochem. 2015;26:883-891
111. Wang LL, Zhang Z, Li Q, et al. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod. 2009;24:562-579
112. Adaikalakoteswari A, Finer S, Voyias PD, et al. Vitamin B12 insufficiency induces cholesterol biosynthesis by limiting s-adenosylmethionine and modulating the methylation of SREBF1 and LDLR genes. Clin Epigenetics. 2015;7:14. doi:10.1186/s13148-015-0046-8
113. Azzi S, Sas TC, Koudou Y, et al. Degree of methylation of ZAC1 (PLAGL1) is associated with prenatal and post-natal growth in healthy infants of the EDEN mother child cohort. Epigenetics. 2014;9:338-345
114. De Vogel S, Bongaerts BWC, Wouters KAD, et al. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer Carcinogenesis. 2008;29:1765-1773
115. Perry C, Yu S, Chen J, et al. Effect of vitamin B6 availability on serine hydroxymethyltransferase in MCF-7 cells. Arch Biochem Biophys. 2007;462:21-27
116. Lightfoot YL, Yang T, Sahay B, et al. Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus. Gut Microbes. 2013;4:84-88
117. Lukovac S, Belzer C, Pellis L, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone hcetylation in mouse gut organoids. MBio. 2014;5:e01438-14. doi:10.1128/mBio.01438-14
118. Giahi L, Aumueller E, Elmadfa I, et al. Regulation of TLR4, p38 MAP kinase, IjB and miRNAs by inactivated strains of lactobacilli in human dendritic cells. Benef Microbes. 2012;3:91-98
119. Ghadimi D, Helwig U, Schrezenmeir J, et al. Epigenetic imprinting by commensal probiotics inhibits the IL-23/IL-17 axis in an in vitro model of the intestinal mucosal immune system. J Leukoc Biol. 2012;92:895-911
120. Zanello G, Berri M, Dupont J, et al. Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One. 2011;6:e18573. doi:10.1371/journal.pone.0018573
121. Veltman K, Hummel S, Cichon C, et al. Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells. Int J Biochem Cell Biol. 2012;44:341-349
122. Sokol H, Seksik P, Furet JP. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183-1189
123. Chen CC, Lin WC, Kong MS, et al. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br J Nutr. 2012;107:1623-1634
124. Iyer C, Kosters A, Sethi G, et al. Probiotic Lactobacillus reuteri promotes TNFinduced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell Microbiol. 2008;10:1442-1452
125. Zhang L, Xu YQ, Liu HY, et al. Evaluation of Lactobacillus rhamnosus GG using an Escherichia coli K88 model of piglet diarrhoea: effects on diarrhoea incidence, faecal microflora and immune responses. Vet Microbiol. 2010;141:142-148
126. Villena J, Kitazawa H. Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol. 2014;4:512. doi:10.3389/fimmu.2013.00512
127. Amaretti A, di Nunzio M, Pompei A, et al. Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Appl Microbiol Biotechnol. 2013;97:809-817
128. Lupton JR. Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr. 2004;134:479-482